2025 annual financial data

Atrium Therapeutics 2025 Net margin

Direct answer

Net margin was -411.88%.

Operating income was -76.81M USD and net income was -76.68M USD.
Operating cash flow was -41.13M USD.

Get free Atrium Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
18.62M USD
Operating income
-76.81M USD
Net income
-76.68M USD
Operating cash flow
-41.13M USD